Medical-grade technology leaders The Global Beauty Group have joined forces with biotech innovators FB Dermatology to bring fluorescent light energy (FLE) treatments to clinics Australia wide with Lumixa.
Lumixa is a non-invasive, biophotonic topical gel that contains a fluorophore with an energy profile unique to the skin health indication being treated – such as rosacea, acne or age management. The gel is applied to the treatment area where it is activated by specific wavelengths of high-powered LED light. The result is the production of fluorescent light energy that stimulates the skin’s repair mechanisms to heal at a cellular level.
Treatments with Lumixa increase collagen production, dramatically reduce and prevent the severity of acne, combat inflammation, reactivate the skin matrix and stimulate fibroblasts.
In clinical studies, skin treated with LED light therapy in conjunction with Lumixa Collagen Booster resulted in an over 400% increase in collagen production compared to skin treated with LED light therapy alone.
CEO and Co-Founder of The Global Beauty Group Kane Hammond is excited to be working with FB Dermatology as official distributors of this innovative new treatment
“We’re thrilled to be working with FB Dermatology to bring skin professionals across Australia this progressive treatment that takes LED Light Therapy to a whole new level. It’s a treatment that provides incredibly satisfying client skin improvement results, as well as rewarding revenue and client retention rates for business owners. Especially when combined with The Global Beauty Group MyFaceMyBody Award winning Education HUB training programs, and our ABIA Wholesaler of the Year winning service and support.
FB Dermatology and The Global Beauty Group have a wonderful alignment in our business approach and values. Our shared vision is to set new industry standards in progressive, non-invasive treatment technology that deliver patient centric solutions on the cutting-edge of medical aesthetics. With Lumixa, it’s very exciting to be supporting clinics deliver the powerful results of fluorescent light energy, especially as this is a treatment that until very recently was only available from certified medical professionals.
With the 2019 launch of the MediLUX to their LUX Series range of Australian researched and developed devices, The Global Beauty Group set new standards in medical-grade, ARTG listed (#317123) LED technology.
Featuring Blue (415nm), Green (520nm), Yellow (590nm), Red (633nm) and Near Infrared (830nm) wavelengths, MediLUX incorporates intuitive user protocols and industry leading power capabilities that allow clinicians to push their LED service potential higher than ever before. According to Kane Hammond, this makes MediLUX the ideal LED device to be partnered with Lumixa to deliver fluorescent light energy treatments.
“MediLUX was designed from the ground up to revolutionise what medical-grade in clinic LED Light Therapy treatments could achieve. The large, easily moveable treatment head comfortably covers the face, neck and decolletage at once and energy output is over 100% more powerful than many leading competitor technologies.
With this high-power ability MediLUX is able to achieve mW/cm2 outputs that produce more consistent and reliable fluorescent light energy results. Many lower powered devices would need the client to be under the light for triple the time MediLUX requires to activate the Lumixa biophotonic topical gel, and in many instances lower powered LED devices wouldn’t be able to achieve the power required to see full benefits of the product at all”.
With impressive treatment results, high-tech delivery and the immediately satisfying “It” factor clients are looking for Lumixa is set to be the LED light therapy upgrade your clients (and clinic) have been waiting for.
For more information on Lumixa or the MediLUX call salon suppliers, The Global Beauty Group on 1300 006 607, or visit www.theglobalbeautygroup.com.au/lumixa
